Darbegen
Product Description
Menagen Pharmaceuticals
-
OM -
2024On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Categories
Specifications
Menagen Pharmaceuticals
-
OM
-
2024On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
More Products from Menagen Pharmaceuticals (2)
-
Product Ezirosy
Treatment for Dyslipidemia -
Product Nitisinone Menagen
Indicated for hereditary tyrosinemia type 1
Menagen Pharmaceuticals resources (1)
-
News taiba Make Strategic Investment in Immuneel Therapeutics to advance CAR T-cell Research and Make Therapies More Affordable
taiba has announced a strategic investment in Immuneel Therapeutics for $12 million.
Recommended Products
-
Product KIPFeR®
KIPFeR® is a food supplement formulated to increase the requirement of iron.
Iron is a microelement present in the body and is essential for the formation of red blood cells and hemoglobin.
In addition, iron plays an important role in promoting energy metabolism and oxygen transport ...
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance